Nordic Capital in €9.6bn pharma exit

Nordic Capital has led a consortium of investors in the sale of pharmaceutical company Nycomed to Takeda Pharmaceutical Company. The deal marks the second time Nordic has sold the Zurich-headquartered business.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this